GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,283,000 | -14.1% | 36,631 | 0.0% | 0.68% | -20.2% |
| Q1 2021 | $1,493,000 | -18.2% | 36,631 | -13.2% | 0.85% | -27.4% |
| Q4 2020 | $1,826,000 | -21.6% | 42,196 | 0.0% | 1.17% | -18.6% |
| Q3 2020 | $2,328,000 | -7.3% | 42,196 | +6.1% | 1.44% | -17.9% |
| Q2 2020 | $2,510,000 | +4.8% | 39,762 | -15.2% | 1.75% | -21.8% |
| Q1 2020 | $2,395,000 | -35.7% | 46,873 | 0.0% | 2.24% | -10.2% |
| Q4 2019 | $3,726,000 | +193.4% | 46,873 | +79.1% | 2.50% | +175.0% |
| Q3 2019 | $1,270,000 | – | 26,176 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |